Literature DB >> 24591150

ROS signalling between endothelial cells and cardiac cells.

Min Zhang1, Ajay M Shah.   

Abstract

The heart contains not only cardiomyocytes but also other cell types such as endothelial cells and fibroblasts. Functional crosstalk among these cell types is important for normal cardiac function and is also involved in disease pathophysiology. Recent data indicate that redox signalling within and between endothelial cells and cardiomyocytes, both through direct and indirect mechanisms, is an important aspect of the functional communication between these cell types. Such signalling influences contractile function, cardiomyocyte growth, hypertrophy, angiogenesis, and fibrosis, and may play an important role in cardiac remodelling in disease.

Entities:  

Keywords:  Cardiomyocyte; Endothelial cell; NADPH oxidase; Nitric oxide; Paracrine; Redox signalling

Mesh:

Substances:

Year:  2014        PMID: 24591150     DOI: 10.1093/cvr/cvu050

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN: 0008-6363            Impact factor:   10.787


  30 in total

1.  Coculture of Endothelial Cells with Human Pluripotent Stem Cell-Derived Cardiac Progenitors Reveals a Differentiation Stage-Specific Enhancement of Cardiomyocyte Maturation.

Authors:  Kaitlin K Dunn; Isabella M Reichardt; Aaron D Simmons; Gyuhyung Jin; Martha E Floy; Kelsey M Hoon; Sean P Palecek
Journal:  Biotechnol J       Date:  2019-05-14       Impact factor: 4.677

2.  Angiogenesis effect of therapeutic ultrasound on ischemic hind limb in mice.

Authors:  Jing-Juan Huang; Yi-Qin Shi; Rui-Lin Li; An Hu; Hong-Sheng Zhou; Qian Cheng; Zheng Xu; Zhi-Ming Yang; Chang-Ning Hao; Jun-Li Duan
Journal:  Am J Transl Res       Date:  2014-11-22       Impact factor: 4.060

Review 3.  The epigenetic landscape related to reactive oxygen species formation in the cardiovascular system.

Authors:  Thomas Kietzmann; Andreas Petry; Antonina Shvetsova; Joachim M Gerhold; Agnes Görlach
Journal:  Br J Pharmacol       Date:  2017-05-10       Impact factor: 8.739

4.  Increased mitochondrial prooxidant activity mediates up-regulation of Complex I S-glutathionylation via protein thiyl radical in the murine heart of eNOS(-/-).

Authors:  Patrick T Kang; Chwen-Lih Chen; Yeong-Renn Chen
Journal:  Free Radic Biol Med       Date:  2014-11-28       Impact factor: 7.376

5.  The NADPH oxidase NOX4 promotes the directed migration of endothelial cells by stabilizing vascular endothelial growth factor receptor 2 protein.

Authors:  Kei Miyano; Shuichiro Okamoto; Akira Yamauchi; Chikage Kawai; Mizuho Kajikawa; Takuya Kiyohara; Minoru Tamura; Masahiko Taura; Futoshi Kuribayashi
Journal:  J Biol Chem       Date:  2020-07-02       Impact factor: 5.157

Review 6.  Regulation of coronary blood flow in health and ischemic heart disease.

Authors:  Dirk J Duncker; Akos Koller; Daphne Merkus; John M Canty
Journal:  Prog Cardiovasc Dis       Date:  2014-12-02       Impact factor: 8.194

7.  Human iPSC-derived myocardium-on-chip with capillary-like flow for personalized medicine.

Authors:  Bradley W Ellis; Aylin Acun; U Isik Can; Pinar Zorlutuna
Journal:  Biomicrofluidics       Date:  2017-03-16       Impact factor: 2.800

8.  Donor-specific phenotypic variation in hiPSC cardiomyocyte-derived exosomes impacts endothelial cell function.

Authors:  Amy Turner; Praful Aggarwal; Andrea Matter; Benjamin Olson; C Charles Gu; Steven C Hunt; Cora E Lewis; Donna K Arnett; Rachel Lorier; Ulrich Broeckel
Journal:  Am J Physiol Heart Circ Physiol       Date:  2021-01-08       Impact factor: 4.733

9.  Molecular Signature of Nitroso-Redox Balance in Idiopathic Dilated Cardiomyopathies.

Authors:  Sara Menazza; Angel Aponte; Junhui Sun; Marjan Gucek; Charles Steenbergen; Elizabeth Murphy
Journal:  J Am Heart Assoc       Date:  2015-09-22       Impact factor: 5.501

10.  Antioxidant Properties of Whole Body Periodic Acceleration (pGz).

Authors:  Arkady Uryash; Jorge Bassuk; Paul Kurlansky; Francisco Altamirano; Jose R Lopez; Jose A Adams
Journal:  PLoS One       Date:  2015-07-02       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.